Search Results - "BROCQ, O"

Impact of Home Confinement During the COVID‐19 Pandemic on Medication Use and Disease Activity in Spondyloarthritis Patients by Roux, C. H., Brocq, O., Gerald, F., Pradier, C., Bailly, L.

Get full text

Clinical impact of COVID-19 on a French population of spondyloarthritis patients by Roux, Christian Hubert, Brocq, O., Gerald, F., Pradier, C., Bailly, L.

Get full text

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy by Roux, C. H., Brocq, O., Breuil, V., Albert, C., Euller-Ziegler, L.

“…Objectives. Anti-tumour necrosis factor (TNF)-α therapies are considered category B drugs for pregnancy. Although sometimes prescribed to women of reproductive…”
Get full text

Safety of anti-TNF-α therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis by ROUX, C. H, BROCQ, O, BREUIL, V, ALBERT, C, EULLER-ZIEGLER, L

“…To assess the safety of anti-tumour necrosis factor (TNF)-alpha therapy in patients with rheumatoid arthritis (RA) or spondylarthropathies (SA) and concurrent…”
Get full text

Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor–α Antagonists by Tubach, F., Ravaud, P., Salmon-Céron, D., Petitpain, N., Brocq, O., Grados, F., Guillaume, J. C., Leport, J., Roudaut, A., SolauGervais, E., Lemann, M., Mariette, X., Lortholary, O.

“…Background. Patients treated with tumor necrosis factor–α (TNF-α) antagonists have an increased risk of infection, but infection due to Legionella pneumophila…”
Get full text

Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes by DOUGADOS, M, RIPERT, M, HILLIQUIN, P, BROCQ, O, BRAULT, Y, LOGEART, I

“…Onset of action is considered to be a key characteristic of the treatment of rheumatoid arthritis. The efficacy of TNF blockers is usually evaluated after 2 to…”
Get full text

Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis by Breuil, V, Brocq, O, Pellegrino, C, Grimaud, A, Euller-Ziegler, L

Get full text

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-  therapy reply to correspondence: reply by Roux, C. H., Brocq, O., Euller-Ziegler, L.

Get full text

Approaches in injections for radicular pain: The transforaminal, epidural and transfacet approaches by Brunner, P, Amoretti, N, Soares, F, Brunner, E, Cazaux, É, Brocq, O, Chanalet, S, Liberatore, M, Cucchi, J.-M, Mourou, M.-Y, Michelozzi, G, Robino, C

“…Abstract Spinal injections must be carried out adhering to very strict conditions. However, these procedures have almost come to be seen as everyday and may be…”
Get full text

Reply: Safety of anti-TNF-  therapy in rheumatoid arthritis (RA) and spondylarthropathies (SA) with concurrent B or C chronic hepatitis by Roux, C. H., Gelsi, E., Brocq, O., Euller-Ziegler, L.

Get full text

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-  therapy by Roux, C. H., Brocq, O., Breuil, V., Albert, C., Euller-Ziegler, L.

“…Objectives. Anti-tumour necrosis factor (TNF)-α therapies are considered category B drugs for pregnancy. Although sometimes prescribed to women of reproductive…”
Get full text

Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients by Brocq, Olivier, Tran, Gali, Breuil, Véronique, Grisot, Christian, Flory, Philippe, Euller-Ziegler, Liana

“…We studied the short-term safety and efficacy of intraarticular hylan G-F 20 (Synvisc®) in patients with symptomatic hip osteoarthritis. Methods. In this…”
Get full text

Safety of anti-TNF-  therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis by Roux, C. H., Brocq, O., Breuil, V., Albert, C., Euller-Ziegler, L.

“…Objective. To assess the safety of anti-tumour necrosis factor (TNF)-α therapy in patients with rheumatoid arthritis (RA) or spondylarthropathies (SA) and…”
Get full text

Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients by Brocq, O., Albert, C., Roux, C., Gerard, D., Breuil, V., Ziegler, L. Euller

Get full text

Pleural amyloidosis as the first sign of IgD multiple myeloma by Roux, Christian Hubert, Breuil, V, Brocq, O, Euller-Ziegler, L

“…We describe a case of IgD myeloma with amyloid and plasmocytic pleural localisations. At the onset of the disease it mimicked rheumatoid arthritis, which can…”
Get full text

Insufficiency fracture of the sacrum revealing a pregnancy associated osteoporosis. First case report by BREUIL, VÉRONIQUE, BROCQ, OLIVIER, EULLER-ZIEGLER, LIANA, GRIMAUD, ANNE

“…Biological markers Patient Normal range for our laboratory Serum calcaemia 2.46 mmol/l 2.2-2.6 Serum phosphorus 1.07 mmol/l 0.98-1.3 Alkaline phosphatase 140…”
Get full text

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium by Hässler, Signe, Bachelet, Delphine, Duhaze, Julianne, Szely, Natacha, Gleizes, Aude, Hacein-Bey Abina, Salima, Aktas, Orhan, Auer, Michael, Avouac, Jerôme, Birchler, Mary, Bouhnik, Yoram, Brocq, Olivier, Buck-Martin, Dorothea, Cadiot, Guillaume, Carbonnel, Franck, Chowers, Yehuda, Comabella, Manuel, Derfuss, Tobias, De Vries, Niek, Donnellan, Naoimh, Doukani, Abiba, Guger, Michael, Hartung, Hans-Peter, Kubala Havrdova, Eva, Hemmer, Bernhard, Huizinga, Tom, Ingenhoven, Kathleen, Hyldgaard-Jensen, Poul Erik, Jury, Elizabeth C, Khalil, Michael, Kieseier, Bernd, Laurén, Anna, Lindberg, Raija, Loercher, Amy, Maggi, Enrico, Manson, Jessica, Mauri, Claudia, Mohand Oumoussa, Badreddine, Montalban, Xavier, Nachury, Maria, Nytrova, Petra, Richez, Christophe, Ryner, Malin, Sellebjerg, Finn, Sievers, Claudia, Sikkema, Dan, Soubrier, Martin, Tourdot, Sophie, Trang, Caroline, Vultaggio, Alessandra, Warnke, Clemens, Spindeldreher, Sebastian, Dönnes, Pierre, Hickling, Timothy P, Hincelin Mery, Agnès, Allez, Matthieu, Deisenhammer, Florian, Fogdell-Hahn, Anna, Mariette, Xavier, Pallardy, Marc, Broët, Philippe

“…Biopharmaceutical products (BPs) are widely used to treat autoimmune diseases, but immunogenicity limits their efficacy for an important proportion of…”
Get full text

Switch étanercept-infliximab dans la polyarthrite rhumatoïde : 14 patients sur 131 traités par anti-TNFα by BROCQ, O, PLUBEL, Y, BREUIL, V, GRISOT, C, FLORY, P, MOUSNIER, A, EULLER-ZIELER, L

Get full text

Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor-  Antagonists by Tubach, F., Ravaud, P., Salmon-Ceron, D., Petitpain, N., Brocq, O., Grados, F., Guillaume, J. C., Leport, J., Roudaut, A., SolauGervais, E., Lemann, M., Mariette, X., Lortholary, O.

Get full text

Légionellose chez une patiente sous infliximab by Albert, C, Vandenbos, F, Brocq, O, Carles, D, Euller-Ziegler, L

Get full text